CEO - Ariba & Mac Limited, Saudi Arabia
A distinguished scientist, inventor, trainer, and educator, Prof. Irfan Jamil is recognized globally as an expert in GMP, Regulatory compliance, R&D, and Technology Transfer facilitation — a reputation built over more than three decades of excellence in science and innovation.
He is the inventor of the world’s first Ibuprofen infusion and holds several international patents filed through WIPO/PCT, secured in the USA, Australia, Canada, Europe, Saudi Arabia, GCC, Japan, South Korea, China, Pakistan and India.
A versatile chemical scientist, Prof. Jamil is also known for his pioneering work in supramolecular chemistry, advanced materials, electro ceramics, superconducting materials, crystallography, XRD, XRF, and organometallic chemical vapor deposition (OMCVD). He has conducted research on the effect of electron-donating groups on metal complexes and supervised numerous research projects at renowned academic and research institutions.
His expertise extends to:
Above all, Prof. Irfan Jamil’s research drives the Ariba & Mac Limited vision of becoming a respected, profitable, and fully integrated International Research and Innovation Center. His focused approach and enduring passion for cutting-edge technologies define his ongoing mission to push the frontiers of science and innovation.
Prof. Irfan Jamil’s expertise lies in regulatory science, advanced chemistry, and technology-driven innovation. His leadership integrates scientific research with industrial application, fostering GMP excellence, product development, and technology transfer across international platforms.